4-(Methylamino)-3-Nitrobenzoic Acid

Product Overview

4-(Methylamino)-3-Nitrobenzoic Acid is a highly specialized organic compound serving as a critical building block in the modern pharmaceutical industry. Recognized by its unique chemical structure and specific reactivity profile, this substance plays an indispensable role in the synthesis of advanced therapeutic agents. Our manufacturing process ensures that every batch meets rigorous international standards for purity, consistency, and safety, making it a reliable choice for large-scale pharmaceutical production and research development.

As a key intermediate, this compound is primarily utilized in the production of Dabigatran Etexilate Mesylate, a widely prescribed anticoagulant medication used globally. The stability and chemical properties of 4-(Methylamino)-3-Nitrobenzoic Acid make it ideal for the complex organic synthesis routes required in modern drug development. We prioritize quality control at every stage of production, from raw material sourcing to final packaging, ensuring that our clients receive a product that facilitates efficient downstream processing and minimizes production delays.

Technical Specifications

Our commitment to excellence is reflected in the detailed physical and chemical properties of this product. The following table outlines the standard specifications guaranteed for each shipment. We maintain strict adherence to these parameters to support seamless integration into your manufacturing workflows and ensure regulatory compliance.

Industrial Applications

The primary application of 4-(Methylamino)-3-Nitrobenzoic Acid lies within the pharmaceutical sector, specifically as a precursor for cardiovascular medications. It is a vital intermediate in the synthesis of Dabigatran Etexilate, which is used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. The high purity level of our product ensures minimal impurity carryover, which is crucial for meeting strict regulatory requirements in drug manufacturing.

• Essential intermediate for anticoagulant drug synthesis.
• Supports scalable production of Dabigatran Etexilate Mesylate.
• Compatible with various organic synthesis pathways.
• Ensures high yield and reproducibility in final API production.
• Suitable for research and development of new therapeutic formulations.

Quality Assurance and Safety Handling

We understand that safety and compliance are paramount in the chemical industry. Our facility operates under strict quality management systems to guarantee product integrity and traceability. Each batch is accompanied by a comprehensive Certificate of Analysis (COA) verifying all critical parameters including identity, purity, and physical constants. Proper handling procedures should be followed to maintain safety standards during transport, storage, and usage within your facility.

Storage recommendations include keeping the material in a cool, ventilated area away from incompatible substances such as strong oxidizing agents. The product is typically packaged in 25 kg drums, with custom packaging options available to suit specific logistical requirements and bulk orders. By choosing our supply, you gain access to a global manufacturer dedicated to supporting the pharmaceutical supply chain with reliability, technical expertise, and excellence.

Why Choose Our Supply

Partnering with us means securing a stable supply chain for critical pharmaceutical intermediates. We offer competitive bulk pricing, timely global shipping, and dedicated technical support to assist with your synthesis requirements. Our team is committed to fostering long-term relationships based on trust and quality performance.